Skip navigation

 Login or Register | Member Centre

Posted AT 8:43 PM EDT on 15/11/05

Biovail pitches dividend plan

From Wednesday's Globe and Mail

Drug developer Biovail Corp. surprised investors yesterday by unveiling a dividend policy together with plans to spin off its legacy line of non-core products to existing shareholders. The spinoff is part of a broader restructuring initiated by the company's new chief executive officer Doug Squires. Earlier this year, the company abandoned the bulk of its U.S.

The full text of this article has 591 words.

To continue reading this article, you will need to purchase this article.

Already have a member account? Login now

Pay-Per-View Offers To read the complete article, select one of the following options

Purchasing from globeandmail.com is quick and secure.

Single Article: $4.95

4-pack: $17.95

Back to top